The drug Daraprim treats toxoplasmosis, a parasite that causes illness in those with weakened immune systems.
Turing Pharmaceuticals on Tuesday afternoon announced they would lower the cost of the life-saving drug. The new price was not released but he Shkreli stated the determination would be made in the next few weeks.
Shkreli said the reduction in price was a reaction to the outrage over the increase.
I guess some people think Daraprim access will decline instead of increase. I guarantee better access at lower prices to patients than ever.— Martin Shkreli (@MartinShkreli) September 21, 2015